Research of the EML4-ALK Gene Expression in the Pleural Effusion or Tumor Tissue From Lung Cancer Patients

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Lung Cancer Patients Clinical Trial

Official title:
Research of the EML4-ALK Gene Expression in the Pleural Effusion or Tumor Tissue From Lung Cancer Patients

Status Enrolling by invitation

Clinical Trial Summary

We wants to analyse the EML4-ALK mutation rate in the patients who have non-small cell lung cancer.

n/a

Time Perspective: Prospective

NCT number	NCT01257308
Study type	Observational
Source	Taipei Medical University WanFang Hospital
Contact
Status	Enrolling by invitation
Phase	N/A
Start date	August 2010
Completion date	August 2013

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT06331455` - Treatment of Pulmonary SUlcus, Pancoast and Chest Wall Non-small Cell Lung Cancer Employing Radiation, Immuno-oncology and Resection	Phase 2
Completed	`NCT03482323` - Aerobic Exercise and Tai-chi Interventions for Improving Survival in Lung Cancer Patients	N/A
Recruiting	`NCT05826756` - Project PEER: Understanding the Lung Cancer Patient ExperiEnce in the Real-World Setting
Completed	`NCT01213654` - Inter Costal Catheters for Video-Assisted Thoroscopic (VATS) Lobectomy	N/A